Principal Research Scientist @ Eli Lilly and Company
Mark Uhlik's Education
University of North Carolina at Chapel Hill School of Medicine
Post-Doc (Pharmacology)
2003 - 2004
University of Colorado Health Sciences Center
Post-Doc (Pharmacology)
2001 - 2003
Penn State University College of Medicine
PhD (Microbiology and Immunology)
1995 - 2001
Colorado State University
BS (Microbiology)
1991 - 1995
Mark Uhlik's Skills
Drug Discovery
Drug Development
Biomarkers
Oncology
Pharmacology
Clinical Development
In Vivo
In Vitro
Biotechnology
Lifesciences
Mark Uhlik's Summary
Mark Uhlik, based in Waltham, MA, US, is currently a Vice President, Head of Research and Biomarker Discovery at OncXerna Therapeutics, bringing experience from previous roles at HiberCell, Biothera and Eli Lilly and Company. Mark Uhlik holds a 2003 - 2004 Post-Doc in Pharmacology @ University of North Carolina at Chapel Hill School of Medicine. With a robust skill set that includes Drug Discovery, Drug Development, Biomarkers, Oncology, Pharmacology and more, Mark Uhlik contributes valuable insights to the industry. Mark Uhlik has 3 emails and 1 mobile phone number on RocketReach.